A detailed history of Avantax Advisory Services, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 2,382 shares of LNTH stock, worth $243,273. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,382
Previous 2,250 5.87%
Holding current value
$243,273
Previous $246,000 13.41%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$76.22 - $116.71 $10,061 - $15,405
132 Added 5.87%
2,382 $213,000
Q3 2024

Nov 13, 2024

BUY
$77.7 - $123.62 $174,825 - $278,145
2,250 New
2,250 $246,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.02B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.